Roxindole is a chemical compound classified as a serotonin receptor agonist, primarily targeting the 5-HT1A and 5-HT2 receptors. It is known for its potential use in the treatment of various psychiatric disorders, particularly depression and anxiety. The compound exhibits a unique pharmacological profile, which may contribute to its efficacy in modulating mood and behavior. Roxindole is characterized by its relatively low solubility in water, which can influence its bioavailability and absorption in biological systems. Additionally, it has a moderate lipophilicity, allowing it to cross biological membranes effectively. The compound's structure includes a bicyclic framework, which is common among many psychoactive substances, contributing to its interaction with neurotransmitter systems. As with many pharmacologically active compounds, the safety and side effect profile of Roxindole is an important consideration in its therapeutic application, necessitating further research to fully understand its pharmacodynamics and pharmacokinetics. Overall, Roxindole represents a significant interest in the field of psychopharmacology.

Roxindole

112192-04-8: 1H-Indol-5-ol, 3-[4-(3,6-dihydro-4-phenyl-1(2H)-pyridinyl)butyl]-, 3-(4-(3,6-Dihydro-4-phenyl-1(2H)-pyridinyl)butyl)-1H-indol-5-ol, 3-(4-(3,6-Dihydro-4-phenyl-1(2H)-pyridylbutyl)indol-5-ol, 3-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-yl)butyl]-1H-indol-5-ol, Roxindole [INN], Unii-43227Sms0O, Roxindole

Roxindole: dopamine agonist, serotonin reuptake inhibitor, 5-HT1A agonist, developed for schizophrenia.

CAS 112192-04-8: Roxindole

Roxindole

Ref: 54-BUP03398

Roxindole

Ref: TM-T26126